Report Library
View More
Bladder Cancer KOL Interview - US, ...
March 24, 2025
Datamonitor Healthcare CV&Met: Veno...
March 21, 2025
Datamonitor Healthcare CV&Met: Atri...
March 21, 2025
Datamonitor Healthcare Respiratory:...
March 21, 2025
Datamonitor Healthcare Oncology: Ne...
March 21, 2025
Datamonitor Healthcare Oncology: Sm...
March 21, 2025
Rare Disease- Myasthenia Gravis
March 11, 2025
Podcast: Vaccines, Viruses & Varian...
March 11, 2025
Datamonitor Healthcare CV&Met: Chem...
March 10, 2025
Datamonitor Healthcare CV&Met: Amyl...
March 10, 2025
Datamonitor Healthcare I&I: Glaucom...
March 10, 2025
Dealmaking Quarterly Statistics, Q4...
March 4, 2025
Financing Quarterly Statistics, Q4 ...
March 4, 2025
Datamonitor Healthcare Oncology: Gl...
February 28, 2025
Datamonitor Healthcare Other: Erect...
February 28, 2025
Depression KOL Interview - US, Sout...
February 27, 2025
Datamonitor Healthcare I&I: Systemi...
February 21, 2025
Datamonitor Healthcare Other: Hypog...
February 21, 2025
Datamonitor Healthcare CNS: Neuropa...
February 21, 2025
2024 Biomedtracker / Datamonitor He...
February 18, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 3/31/25 | Corcept Therapeutics (CORT) | Relacorilant for Ovarian Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/31/25 | AstraZeneca (AZN) | AZD0780 for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/31/25 | Vaxcyte (PCVX) | VAX-24 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/30/25 | Eli Lilly (LLY) | Lepodisiran for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/29/25 | Novo Nordisk (NVO) | Rybelsus for Cardiovascular Disease | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/26/2025 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 03/27/2025 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 03/31/2025 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| 03/31/2025 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation (Emerging Markets) |
| 03/31/2025 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |